title: No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
authors.forename: N
authors.initials: N
authors.lastname: Dupin
authors.forename: A
authors.initials: A
authors.lastname: Krivine
authors.forename: V
authors.initials: V
authors.lastname: Calvez
authors.forename: I
authors.initials: I
authors.lastname: Gorin
authors.forename: N
authors.initials: N
authors.lastname: Franck
authors.forename: J P
authors.initials: JP
authors.lastname: Escande
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D005871:Castleman Disease / Q000175:diagnosis* / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D019288:Herpesvirus 8, Human / Q000187:drug effects / Q000254:growth & development; D018451:Homosexuality, Male; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D008297:Male; D012367:RNA, Viral / Q000032:analysis
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019469:Indinavir